Literature DB >> 16243292

Fibrocystin interacts with CAML, a protein involved in Ca2+ signaling.

Junko Nagano1, Kenichiro Kitamura, Kristine M Hujer, Christopher J Ward, Richard J Bram, Ulrich Hopfer, Kimio Tomita, Chunfa Huang, R Tyler Miller.   

Abstract

The predicted structure of the autosomal recessive polycystic kidney disease protein, fibrocystin, suggests that it may function as a receptor, but its function remains unknown. To understand its function, we searched for proteins that interact with the intracellular C-terminus of fibrocystin using the yeast two-hybrid system. From the screening, we found calcium modulating cyclophilin ligand (CAML), a protein involved in Ca(2+) signaling. Immunofluorescent analysis showed that both proteins are co-localized in the apical membrane, primary cilia, and the basal body of cells derived from the distal nephron Epitope-tagged expression constructs of both proteins were co-immunoprecipitated from COS7 cells. The intracellular C-terminus of fibrocystin interacts with CAML, a protein with an intracellular distribution that is similar to that of PKD2. Fibrocystin may participate in regulation of intracellular Ca(2+) in the distal nephron in a manner similar to PKD1 and PKD2 that are involved in autosomal dominant polycystic kidney disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16243292     DOI: 10.1016/j.bbrc.2005.10.022

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: summary statement of a first National Institutes of Health/Office of Rare Diseases conference.

Authors:  Meral Gunay-Aygun; Ellis D Avner; Robert L Bacallao; Peter L Choyke; Joseph T Flynn; Gregory G Germino; Lisa Guay-Woodford; Peter Harris; Theo Heller; Julie Ingelfinger; Frederick Kaskel; Robert Kleta; Nicholas F LaRusso; Parvathi Mohan; Gregory J Pazour; Benjamin L Shneider; Vicente E Torres; Patricia Wilson; Colleen Zak; Jing Zhou; William A Gahl
Journal:  J Pediatr       Date:  2006-08       Impact factor: 4.406

2.  Comprehensive genetic testing in children with a clinical diagnosis of ARPKD identifies phenocopies.

Authors:  Tamás Szabó; Petronella Orosz; Eszter Balogh; Eszter Jávorszky; István Máttyus; Csaba Bereczki; Zoltán Maróti; Tibor Kalmár; Attila J Szabó; George Reusz; Ildikó Várkonyi; Erzsébet Marián; Éva Gombos; Orsolya Orosz; László Madar; György Balla; János Kappelmayer; Kálmán Tory; István Balogh
Journal:  Pediatr Nephrol       Date:  2018-06-28       Impact factor: 3.714

Review 3.  Ciliary dysfunction in polycystic kidney disease: an emerging model with polarizing potential.

Authors:  Robert J Kolb; Surya M Nauli
Journal:  Front Biosci       Date:  2008-05-01

Review 4.  Diagnosis, pathogenesis, and treatment prospects in cystic kidney disease.

Authors:  Carsten Bergmann; Valeska Frank; Fabian Küpper; Dirk Kamitz; Jens Hanten; Peter Berges; Silke Mager; Markus Moser; Jutta Kirfel; Reinhard Büttner; Jan Senderek; Klaus Zerres
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

5.  Activation of Trpv4 reduces the hyperproliferative phenotype of cystic cholangiocytes from an animal model of ARPKD.

Authors:  Sergio A Gradilone; Tatyana V Masyuk; Bing Q Huang; Jesus M Banales; Guillermo L Lehmann; Brynn N Radtke; Angela Stroope; Anatoliy I Masyuk; Patrick L Splinter; Nicholas F LaRusso
Journal:  Gastroenterology       Date:  2010-04-14       Impact factor: 22.682

Review 6.  Primary cilia and kidney injury: current research status and future perspectives.

Authors:  Shixuan Wang; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-31

Review 7.  Therapeutic Targets in Polycystic Liver Disease.

Authors:  Tatyana V Masyuk; Anatoliy I Masyuk; Nicholas F LaRusso
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

8.  Transmembrane and ubiquitin-like domain containing 1 (Tmub1) regulates locomotor activity and wakefulness in mice and interacts with CAMLG.

Authors:  Wandong Zhang; Katerina V Savelieva; Adisak Suwanichkul; Daniel L Small; Laura L Kirkpatrick; Nianhua Xu; Thomas H Lanthorn; Gui-Lan Ye
Journal:  PLoS One       Date:  2010-06-22       Impact factor: 3.240

9.  Abnormalities in focal adhesion complex formation, regulation, and function in human autosomal recessive polycystic kidney disease epithelial cells.

Authors:  Sharon Israeli; Kurt Amsler; Nadezhda Zheleznova; Patricia D Wilson
Journal:  Am J Physiol Cell Physiol       Date:  2009-11-18       Impact factor: 4.249

10.  MUC1 mucin interacts with calcium-modulating cyclophilin ligand.

Authors:  Wei Guang; K Chul Kim; Erik P Lillehoj
Journal:  Int J Biochem Cell Biol       Date:  2008-12-14       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.